Oppenheimer Asset Management’s Immunomedics Inc IMMU Stock Holding History

Oppenheimer Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-26,872	Closed	-$2.29M	–	1177
2020 Q3	$2.29M	Sell	26,872 -6,739	-20%	-$341K	0.04%	400
2020 Q2	$1.19M	Buy	33,611 +767	+2%	+$22.4K	0.02%	545
2020 Q1	$443K	Sell	32,844 -50	-0.2%	-$841	0.01%	775
2019 Q4	$696K	Buy	32,894 +6,685	+26%	+$118K	0.01%	720
2019 Q3	$348K	Sell	26,209 -454	-2%	-$6.67K	0.01%	895
2019 Q2	$370K	Sell	26,663 -4,099	-13%	-$61.7K	0.01%	899
2019 Q1	$591K	Buy	+30,762	New	+$496K	0.01%	751

Oppenheimer Asset Management's IMMU Position: Q4 2020 in Review

Oppenheimer Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 26,872 shares — an estimated $2.29M sold.

Oppenheimer Asset Management first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $2.29M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Oppenheimer Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Oppenheimer Asset Management sold 26,872 Immunomedics Inc shares in Q4 2020, an estimated $2.29M.
Oppenheimer Asset Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
Oppenheimer Asset Management's Immunomedics Inc position peaked at $2.29M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Oppenheimer Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.